Cancer

  • ​McCarroll JA, Dwarte T, Baigude H, Dang J, Yang L, Erlich RB, Kimpton K, Teo J, Sagnella SM, Akerfeldt MC, et al. (2015). Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer. Oncotarget, 6, 12020-12034. DOI: 10.18632/oncotarget.2664
  •  Zhou Y, Dang J, Chang KY, Yau E, Aza-Blanc P, Moscat J, and Rana TM. (2016). miR-1298 inhibits mutant KRAS-driven tumor growth by repressing FAK and LAMB3. Cancer Res, 76, 5777-5787. DOI: 10.1158/0008-5472.CAN-15-2936
  •  Yau EH, Kummetha IR, Lichinchi G, Tang R, Zhang Y, and Rana TM (2017) Genome-wide CRISPR screen for essential cell growth mediators in mutant KRAS colorectal cancers. Cancer Research, 77, 6330-6339. DOI: 10.1158/0008-5472.CAN-17-2043
  •  Yau EH and Rana TM. (2018). Next-generation sequencing of genome-wide CRISPR screens. Methods in Molecular Biology 1712, 203-216. DOI: 10.1007/978-1-4939-7514-3_13